Trace Determination of Tamoxifen using Optimized Solvent Bar Microextraction and HPLC-UV

Tamoxifen (Soltamox) is an antineoplastic agent and an estrogen receptor antagonist used to treat breast cancer, but have severe side effects such as hot flashes, vaginal discharge, etc. Dose monitoring is a necessity for optimum treatment, to prevent severe adverse effects. In this study, the solvent bar microextraction method (SBME) was used for preconcentration and microextraction coupled with High-performance liquid chromatography-ultraviolet (HPLC-UV) analysis of tamoxifen. The limit of detection and limit of quantification were 13.3 and 40 μgL-1, respectively. The linear range was between 40 and 10000 μgL-1 with a correlation coefficient of 0.999. The enrichment factor was 169 and the relative standard deviation within-day and between-day were 3.6 and 4.0, respectively. The use of sensitive SBME method coupled with HPLC-UV analysis for detection of tamoxifen at trace level proved to be successful, offering a desirable preconcentration factor, and a costeffective and green set-up for determining its rate of elimination from cancer patients and wastewater.

[1]  M. Qomi,et al.  Preconcentration and Determination of Cabergoline Using the Green Practical Solvent Bar Liquid Phase Microextraction Technique in Biological Fluids , 2018, Current Pharmaceutical Analysis.

[2]  N. Ghasemi,et al.  Optimization of Extraction and Pre-Concentration of Rizatriptan in Biological Samples Using Solvent Bar and Chemometrics Design , 2018, Current Pharmaceutical Analysis.

[3]  K. Tennekoon,et al.  CYP2D6 polymorphisms may predict occurrence of adverse effects to tamoxifen: a preliminary retrospective study , 2017, Breast cancer.

[4]  M. Breadmore,et al.  Electrokinetic supercharging in nonaqueous capillary electrophoresis for online preconcentration and determination of tamoxifen and its metabolites in human plasma. , 2016, Journal of chromatography. A.

[5]  J. Raoof,et al.  SiO2 nanoparticles modified CPE as a biosensor for determination of i-motif DNA/Tamoxifen interaction. , 2016, International journal of biological macromolecules.

[6]  M. Qomi,et al.  Hollow-Fiber liquid-phase Microextraction Followed by High Performance Liquid Chromatography for the Determination of Trace Amounts of Methylphenidate Hydrochloride in Biological Fluids , 2014 .

[7]  M. Rambla-Alegre,et al.  Tamoxifen monitoring studies in breast cancer patients by micellar liquid chromatography , 2010, Analytical and bioanalytical chemistry.

[8]  Hian Kee Lee,et al.  Environmental and bioanalytical applications of hollow fiber membrane liquid-phase microextraction: a review. , 2008, Analytica chimica acta.

[9]  M. Goetz,et al.  Tamoxifen Pharmacogenomics: The Role of CYP2D6 as a Predictor of Drug Response , 2008, Clinical pharmacology and therapeutics.

[10]  M Baum,et al.  Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer , 2005, The Lancet.

[11]  Hian Kee Lee,et al.  Solvent bar microextraction. , 2004, Analytical chemistry.

[12]  D. Flockhart,et al.  Quantification of tamoxifen and three metabolites in plasma by high-performance liquid chromatography with fluorescence detection: application to a clinical trial. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.